Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Cnbx Pharmaceuticals Inc (CNBX)

Cnbx Pharmaceuticals Inc (CNBX)
N/A x N/A N/A x N/A
Pre-market by (Cboe BZX)
0.0090 unch (unch) 01/17/25 [OTC US]
N/A x N/A N/A x N/A
Pre-market 0.0090 unch (unch) 09:53 ET
Quote Overview for Fri, Jan 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.0083
Day High
0.0090
Open 0.0085
Previous Close 0.0090 0.0090
Volume 51,000 51,000
Avg Vol 115,455 115,455
Stochastic %K 85.42% 85.42%
Weighted Alpha +13.55 +13.55
5-Day Change +0.0018 (+25.00%) +0.0018 (+25.00%)
52-Week Range 0.0050 - 0.0199 0.0050 - 0.0199
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.37
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0053 +69.81%
on 12/23/24
Period Open: 0.0060
0.0099 -9.09%
on 01/16/25
+0.0030 (+50.00%)
since 12/17/24
3-Month
0.0050 +80.00%
on 10/28/24
Period Open: 0.0108
0.0199 -54.77%
on 10/21/24
-0.0018 (-16.67%)
since 10/17/24
52-Week
0.0050 +80.00%
on 10/28/24
Period Open: 0.0179
0.0199 -54.77%
on 10/21/24
-0.0089 (-49.72%)
since 01/17/24

Most Recent Stories

More News
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0090 (unch)
CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel

/PRNewswire/ - CNBX Pharmaceuticals Inc. (OTC-QB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0090 (unch)
CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today the...

CNBX : 0.0090 (unch)
CNBX Pharmaceuticals Announces New Patent Granted in Australia

/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that...

CNBX : 0.0090 (unch)
Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0090 (unch)
EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0090 (unch)
CNBX Director, Dr. Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las Vegas

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0090 (unch)
CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021

/PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today...

CNBX : 0.0090 (unch)

Business Summary

American Mining Corp was incorporated on September 15, 2004. The Company is an exploration stage company. The Company acquires mineral exploration rights throughout North America, exploring for commercially producible quantities of minerals, and exploiting any mineral deposits which demonstrate economic...

See More

Key Turning Points

3rd Resistance Point 0.0099
2nd Resistance Point 0.0095
1st Resistance Point 0.0092
Last Price 0.0090
1st Support Level 0.0085
2nd Support Level 0.0081
3rd Support Level 0.0078

See More

52-Week High 0.0199
Fibonacci 61.8% 0.0142
Fibonacci 50% 0.0125
Fibonacci 38.2% 0.0107
Last Price 0.0090
52-Week Low 0.0050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Master Swing Trading: Strategies for Momentum and Trends